GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
GE HealthCare announced a global clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system, spanning five institutions including Mayo Clinic, Hadassah, and Peking University First Hospital. Participating sites will assess quantitative, dynamic, and emerging theranostic imaging applications, building on more than 1,000 patient studies completed to date. StarGuide GX is CE-marked and sold in select EU states but remains 510(k) pending with the FDA and unavailable in the U.S., so U.S.
Key figures
- Employees
- approximately 54,000
- Company revenue
- $20.6 billion
- Patient studies
- more than 1,000
- Sensitivity improvement
- up to 2.67-times system volume sensitivity
- Collaborating institutions
- 5
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.